ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-13H8024
Home | Market Reports | Health| Nursing
Global AI to Novel Coronavirus COVID 19 and Epidemic Market Insights and Forecast to 2028
BUY CHAPTERS

Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Research Report 2025

Code: QYRE-Auto-13H8024
Report
June 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GOOGLE INC
Alibaba
Artificial Intelligence in Medical Epidemiology
BlueDot
Beijing Infervision Technology Co., Ltd.
BenevolentAI
SenseTime
InSilico Medicine
DEARGEN
Iktos
SRI Biosciences

AI to Novel Coronavirus (COVID-19) and Epidemic Market Size

In order to maintain its leading position, the United States will increase its investment in artificial intelligence research and development in non-defense fields, from US$1.6 billion to US$1.7 billion in 2022.

AI to Novel Coronavirus (COVID-19) and Epidemic Market

AI to Novel Coronavirus (COVID-19) and Epidemic Market

The global market for AI to Novel Coronavirus (COVID-19) and Epidemic was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
As an important force driving a new round of scientific and technological revolution, artificial intelligence has been of national strategic importance. Many governments introduces polices and increase capital investment to support AI companies. The Digital Europe plan adopted by the European Union will allocate €9.2 billion on high-tech investments, such as supercomputing, artificial intelligence, and network security. According to the latest data released by IDC, global artificial intelligence revenue was US$432.8 billion in 2022, a year-on-year increase of 19.66%, including software, hardware and services.
This report aims to provide a comprehensive presentation of the global market for AI to Novel Coronavirus (COVID-19) and Epidemic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI to Novel Coronavirus (COVID-19) and Epidemic.
The AI to Novel Coronavirus (COVID-19) and Epidemic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI to Novel Coronavirus (COVID-19) and Epidemic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI to Novel Coronavirus (COVID-19) and Epidemic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of AI to Novel Coronavirus (COVID-19) and Epidemic Market Report

Report Metric Details
Report Name AI to Novel Coronavirus (COVID-19) and Epidemic Market
Accounted market size in 2022 US$ billion to US$ 1.7 billion
Base Year 2022
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Google, Alibaba, Artificial Intelligence in Medical Epidemiology, BlueDot, Beijing Infervision Technology Co., Ltd., BenevolentAI, SenseTime, Insilico Medicine, DEARGEN, Iktos, SRI Biosciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of AI to Novel Coronavirus (COVID-19) and Epidemic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the AI to Novel Coronavirus (COVID-19) and Epidemic Market report?

Ans: The main players in the AI to Novel Coronavirus (COVID-19) and Epidemic Market are Google, Alibaba, Artificial Intelligence in Medical Epidemiology, BlueDot, Beijing Infervision Technology Co., Ltd., BenevolentAI, SenseTime, Insilico Medicine, DEARGEN, Iktos, SRI Biosciences

What are the Application segmentation covered in the AI to Novel Coronavirus (COVID-19) and Epidemic Market report?

Ans: The Applications covered in the AI to Novel Coronavirus (COVID-19) and Epidemic Market report are Medical, Public Emergency, Other

What are the Type segmentation covered in the AI to Novel Coronavirus (COVID-19) and Epidemic Market report?

Ans: The Types covered in the AI to Novel Coronavirus (COVID-19) and Epidemic Market report are AI Tracking, AI Predict, AI Recognition, Other

Recommended Reports

COVID Diagnostics

Vaccines & Treatment

AI in Healthcare

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 AI Tracking
1.2.3 AI Predict
1.2.4 AI Recognition
1.2.5 Other
1.3 Market by Application
1.3.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Medical
1.3.3 Public Emergency
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Perspective (2020-2031)
2.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Growth Trends by Region
2.2.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 AI to Novel Coronavirus (COVID-19) and Epidemic Historic Market Size by Region (2020-2025)
2.2.3 AI to Novel Coronavirus (COVID-19) and Epidemic Forecasted Market Size by Region (2026-2031)
2.3 AI to Novel Coronavirus (COVID-19) and Epidemic Market Dynamics
2.3.1 AI to Novel Coronavirus (COVID-19) and Epidemic Industry Trends
2.3.2 AI to Novel Coronavirus (COVID-19) and Epidemic Market Drivers
2.3.3 AI to Novel Coronavirus (COVID-19) and Epidemic Market Challenges
2.3.4 AI to Novel Coronavirus (COVID-19) and Epidemic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI to Novel Coronavirus (COVID-19) and Epidemic Players by Revenue
3.1.1 Global Top AI to Novel Coronavirus (COVID-19) and Epidemic Players by Revenue (2020-2025)
3.1.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Revenue Market Share by Players (2020-2025)
3.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by AI to Novel Coronavirus (COVID-19) and Epidemic Revenue
3.4 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Concentration Ratio
3.4.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI to Novel Coronavirus (COVID-19) and Epidemic Revenue in 2024
3.5 Global Key Players of AI to Novel Coronavirus (COVID-19) and Epidemic Head office and Area Served
3.6 Global Key Players of AI to Novel Coronavirus (COVID-19) and Epidemic, Product and Application
3.7 Global Key Players of AI to Novel Coronavirus (COVID-19) and Epidemic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AI to Novel Coronavirus (COVID-19) and Epidemic Breakdown Data by Type
4.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Historic Market Size by Type (2020-2025)
4.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Forecasted Market Size by Type (2026-2031)
5 AI to Novel Coronavirus (COVID-19) and Epidemic Breakdown Data by Application
5.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Historic Market Size by Application (2020-2025)
5.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size (2020-2031)
6.2 North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2020-2025)
6.4 North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size (2020-2031)
7.2 Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2020-2025)
7.4 Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Size (2020-2031)
8.2 Asia-Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Region (2020-2025)
8.4 Asia-Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size (2020-2031)
9.2 Latin America AI to Novel Coronavirus (COVID-19) and Epidemic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2020-2025)
9.4 Latin America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size (2020-2031)
10.2 Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2020-2025)
10.4 Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Google
11.1.1 Google Company Details
11.1.2 Google Business Overview
11.1.3 Google AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.1.4 Google Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.1.5 Google Recent Development
11.2 Alibaba
11.2.1 Alibaba Company Details
11.2.2 Alibaba Business Overview
11.2.3 Alibaba AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.2.4 Alibaba Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.2.5 Alibaba Recent Development
11.3 Artificial Intelligence in Medical Epidemiology
11.3.1 Artificial Intelligence in Medical Epidemiology Company Details
11.3.2 Artificial Intelligence in Medical Epidemiology Business Overview
11.3.3 Artificial Intelligence in Medical Epidemiology AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.3.4 Artificial Intelligence in Medical Epidemiology Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.3.5 Artificial Intelligence in Medical Epidemiology Recent Development
11.4 BlueDot
11.4.1 BlueDot Company Details
11.4.2 BlueDot Business Overview
11.4.3 BlueDot AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.4.4 BlueDot Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.4.5 BlueDot Recent Development
11.5 Beijing Infervision Technology Co., Ltd.
11.5.1 Beijing Infervision Technology Co., Ltd. Company Details
11.5.2 Beijing Infervision Technology Co., Ltd. Business Overview
11.5.3 Beijing Infervision Technology Co., Ltd. AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.5.4 Beijing Infervision Technology Co., Ltd. Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.5.5 Beijing Infervision Technology Co., Ltd. Recent Development
11.6 BenevolentAI
11.6.1 BenevolentAI Company Details
11.6.2 BenevolentAI Business Overview
11.6.3 BenevolentAI AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.6.4 BenevolentAI Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.6.5 BenevolentAI Recent Development
11.7 SenseTime
11.7.1 SenseTime Company Details
11.7.2 SenseTime Business Overview
11.7.3 SenseTime AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.7.4 SenseTime Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.7.5 SenseTime Recent Development
11.8 Insilico Medicine
11.8.1 Insilico Medicine Company Details
11.8.2 Insilico Medicine Business Overview
11.8.3 Insilico Medicine AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.8.4 Insilico Medicine Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.8.5 Insilico Medicine Recent Development
11.9 DEARGEN
11.9.1 DEARGEN Company Details
11.9.2 DEARGEN Business Overview
11.9.3 DEARGEN AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.9.4 DEARGEN Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.9.5 DEARGEN Recent Development
11.10 Iktos
11.10.1 Iktos Company Details
11.10.2 Iktos Business Overview
11.10.3 Iktos AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.10.4 Iktos Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.10.5 Iktos Recent Development
11.11 SRI Biosciences
11.11.1 SRI Biosciences Company Details
11.11.2 SRI Biosciences Business Overview
11.11.3 SRI Biosciences AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.11.4 SRI Biosciences Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.11.5 SRI Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
GOOGLE INC
Alibaba
Artificial Intelligence in Medical Epidemiology
BlueDot
Beijing Infervision Technology Co., Ltd.
BenevolentAI
SenseTime
InSilico Medicine
DEARGEN
Iktos
SRI Biosciences
List of Tables
 Table 1. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of AI Tracking
 Table 3. Key Players of AI Predict
 Table 4. Key Players of AI Recognition
 Table 5. Key Players of Other
 Table 6. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Region (2020-2025)
 Table 10. Global AI to Novel Coronavirus (COVID-19) and Epidemic Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Region (2026-2031)
 Table 12. AI to Novel Coronavirus (COVID-19) and Epidemic Market Trends
 Table 13. AI to Novel Coronavirus (COVID-19) and Epidemic Market Drivers
 Table 14. AI to Novel Coronavirus (COVID-19) and Epidemic Market Challenges
 Table 15. AI to Novel Coronavirus (COVID-19) and Epidemic Market Restraints
 Table 16. Global AI to Novel Coronavirus (COVID-19) and Epidemic Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Players (2020-2025)
 Table 18. Global Top AI to Novel Coronavirus (COVID-19) and Epidemic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic as of 2024)
 Table 19. Ranking of Global Top AI to Novel Coronavirus (COVID-19) and Epidemic Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by AI to Novel Coronavirus (COVID-19) and Epidemic Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of AI to Novel Coronavirus (COVID-19) and Epidemic, Headquarters and Area Served
 Table 22. Global Key Players of AI to Novel Coronavirus (COVID-19) and Epidemic, Product and Application
 Table 23. Global Key Players of AI to Novel Coronavirus (COVID-19) and Epidemic, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global AI to Novel Coronavirus (COVID-19) and Epidemic Revenue Market Share by Type (2020-2025)
 Table 27. Global AI to Novel Coronavirus (COVID-19) and Epidemic Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global AI to Novel Coronavirus (COVID-19) and Epidemic Revenue Market Share by Type (2026-2031)
 Table 29. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global AI to Novel Coronavirus (COVID-19) and Epidemic Revenue Market Share by Application (2020-2025)
 Table 31. Global AI to Novel Coronavirus (COVID-19) and Epidemic Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global AI to Novel Coronavirus (COVID-19) and Epidemic Revenue Market Share by Application (2026-2031)
 Table 33. North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Google Company Details
 Table 49. Google Business Overview
 Table 50. Google AI to Novel Coronavirus (COVID-19) and Epidemic Product
 Table 51. Google Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
 Table 52. Google Recent Development
 Table 53. Alibaba Company Details
 Table 54. Alibaba Business Overview
 Table 55. Alibaba AI to Novel Coronavirus (COVID-19) and Epidemic Product
 Table 56. Alibaba Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
 Table 57. Alibaba Recent Development
 Table 58. Artificial Intelligence in Medical Epidemiology Company Details
 Table 59. Artificial Intelligence in Medical Epidemiology Business Overview
 Table 60. Artificial Intelligence in Medical Epidemiology AI to Novel Coronavirus (COVID-19) and Epidemic Product
 Table 61. Artificial Intelligence in Medical Epidemiology Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
 Table 62. Artificial Intelligence in Medical Epidemiology Recent Development
 Table 63. BlueDot Company Details
 Table 64. BlueDot Business Overview
 Table 65. BlueDot AI to Novel Coronavirus (COVID-19) and Epidemic Product
 Table 66. BlueDot Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
 Table 67. BlueDot Recent Development
 Table 68. Beijing Infervision Technology Co., Ltd. Company Details
 Table 69. Beijing Infervision Technology Co., Ltd. Business Overview
 Table 70. Beijing Infervision Technology Co., Ltd. AI to Novel Coronavirus (COVID-19) and Epidemic Product
 Table 71. Beijing Infervision Technology Co., Ltd. Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
 Table 72. Beijing Infervision Technology Co., Ltd. Recent Development
 Table 73. BenevolentAI Company Details
 Table 74. BenevolentAI Business Overview
 Table 75. BenevolentAI AI to Novel Coronavirus (COVID-19) and Epidemic Product
 Table 76. BenevolentAI Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
 Table 77. BenevolentAI Recent Development
 Table 78. SenseTime Company Details
 Table 79. SenseTime Business Overview
 Table 80. SenseTime AI to Novel Coronavirus (COVID-19) and Epidemic Product
 Table 81. SenseTime Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
 Table 82. SenseTime Recent Development
 Table 83. Insilico Medicine Company Details
 Table 84. Insilico Medicine Business Overview
 Table 85. Insilico Medicine AI to Novel Coronavirus (COVID-19) and Epidemic Product
 Table 86. Insilico Medicine Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
 Table 87. Insilico Medicine Recent Development
 Table 88. DEARGEN Company Details
 Table 89. DEARGEN Business Overview
 Table 90. DEARGEN AI to Novel Coronavirus (COVID-19) and Epidemic Product
 Table 91. DEARGEN Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
 Table 92. DEARGEN Recent Development
 Table 93. Iktos Company Details
 Table 94. Iktos Business Overview
 Table 95. Iktos AI to Novel Coronavirus (COVID-19) and Epidemic Product
 Table 96. Iktos Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
 Table 97. Iktos Recent Development
 Table 98. SRI Biosciences Company Details
 Table 99. SRI Biosciences Business Overview
 Table 100. SRI Biosciences AI to Novel Coronavirus (COVID-19) and Epidemic Product
 Table 101. SRI Biosciences Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
 Table 102. SRI Biosciences Recent Development
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. AI to Novel Coronavirus (COVID-19) and Epidemic Picture
 Figure 2. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Type: 2024 VS 2031
 Figure 4. AI Tracking Features
 Figure 5. AI Predict Features
 Figure 6. AI Recognition Features
 Figure 7. Other Features
 Figure 8. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Application: 2024 VS 2031
 Figure 10. Medical Case Studies
 Figure 11. Public Emergency Case Studies
 Figure 12. Other Case Studies
 Figure 13. AI to Novel Coronavirus (COVID-19) and Epidemic Report Years Considered
 Figure 14. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Region: 2024 VS 2031
 Figure 17. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Players in 2024
 Figure 18. Global Top AI to Novel Coronavirus (COVID-19) and Epidemic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by AI to Novel Coronavirus (COVID-19) and Epidemic Revenue in 2024
 Figure 20. North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Country (2020-2031)
 Figure 22. United States AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Country (2020-2031)
 Figure 26. Germany AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Region (2020-2031)
 Figure 34. China AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Country (2020-2031)
 Figure 42. Mexico AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Country (2020-2031)
 Figure 46. Turkey AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Google Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
 Figure 50. Alibaba Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
 Figure 51. Artificial Intelligence in Medical Epidemiology Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
 Figure 52. BlueDot Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
 Figure 53. Beijing Infervision Technology Co., Ltd. Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
 Figure 54. BenevolentAI Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
 Figure 55. SenseTime Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
 Figure 56. Insilico Medicine Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
 Figure 57. DEARGEN Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
 Figure 58. Iktos Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
 Figure 59. SRI Biosciences Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Novel Coronavirus COVID 19 Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Coronavirus Infection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Coronavirus Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Coronavirus Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Enterprise Artificial Intelligence AI Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Artificial Intelligence AI Module Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Artificial Intelligence in Machine Learning Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral COVID 19 Antiviral Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
COVID 19 Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Coronavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Specific Antiviral Drugs for COVID 19 Market
Artificial Intelligence AI in Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Artificial Intelligence System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Artificial Intelligence in E commerce Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Novel Coronavirus Inactivated Vaccine Market Research Report 2025
AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
AI in Insurance Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Artificial Intelligence Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Covid 19 Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Artificial Intelligence AI in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Persistent Epithelial Defect Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2O19977
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Intelligent Elderly Care Equipment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E8132
Wed Sep 17 00:00:00 UTC 2025

Add to Cart

Global Radiation Monitoring Systems Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-23I7304
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Global Ophthalmology Homeopathic Products Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8T5982
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions